Edesa Biotech is trading at $2.30, up 7.48%, with no clear company-specific announcement identified to explain the November 6 after-hours move.

  • The latest reported company news was participation in a healthcare conference scheduled for November 9–11; this does not establish a direct catalyst.
  • Broader market conditions were positive, particularly for technology shares, which may have supported risk sentiment but are not a confirmed explanation for the move.
  • After-hours activity details were not provided.